超越BLA的T1D的细胞疗法:向临床实践迈进
Yong Wang1,2,3, YingYing Chen4, James McGarrigle5
1CellTrans, Inc., 2201 W. Campbell Park Dr, Chicago, IL, 60612, USA. yong.wang@usz.ch.
概括
1型糖尿病 (T1D) 治疗正在通过小岛移植进行进展. 获得生物药品许可申请 (BLA) 批准是关键,但需要进一步的创新,以获得广泛的患者访问和克服免疫排斥.
科学领域:
- 免疫学 免疫学 免疫学
- 内分泌学 在内分泌学.
- 再生医学是一种再生医学.
背景情况:
- 1型糖尿病 (T1D) 需要终身胰岛素治疗,因为胰腺β细胞的自身免疫破坏.
- 岛屿移植通过替换这些细胞提供了潜在的治疗方法,但在可访问性和免疫排斥方面面临挑战.
- 生物制品许可申请 (BLA) 批准是对T1D基于细胞疗法的监管接受的关键一步.
研究的目的:
- 审查1型糖尿病岛屿移植的现状和未来方向.
- 检查生物制品许可申请 (BLA) 对基于细胞的疗法的批准的重要性.
- 确定使小岛移植成为可行的治疗选择的关键进展和挑战.
主要方法:
- 对T1D岛屿移植的当前文献的综述.
- 对监管途径的分析,包括生物制品许可申请 (BLA) 审批流程.
- 讨论封装,干细胞衍生小岛,异种移植和基因编辑方面的最新创新.
主要成果:
- 生物制品许可申请 (BLA) 批准是T1D细胞治疗的关键里程碑.
- 封装,干细胞衍生小岛,异种小岛和基因编辑方面的进展对于克服免疫排斥和供应限制至关重要.
- 对于岛屿移植的广泛实施,仍然存在重大的科学,临床和后勤障碍.
结论:
- 虽然BLA的批准是一大步,但要实现T1D岛屿移植的全部潜力,需要解决实际实施的挑战.
- 对细胞来源,输送方法和免疫耐受性策略的持续创新至关重要.
- 合作和战略伙伴关系对于通过细胞疗法改变T1D护理至关重要.
关键词:
生物制品许可申请 (BLA)糖尿病 糖尿病 糖尿病美国食品和药物管理局 (FDA)岛屿封装的封装方式岛屿移植的结果是什么?兰蒂德拉 (兰蒂德拉) 是一个.干细胞是一种干细胞.1型糖尿病 (T1D) 是一种糖尿病.更多相关视频
10:03Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
Published on: November 18, 2022
1.7K
11:31High-Efficiency Generation of Antigen-Specific Primary Mouse Cytotoxic T Cells for Functional Testing in an Autoimmune Diabetes Model
Published on: August 16, 2019
7.8K
相关概念视频
Diabetes: Management and Pharmacotherapy
216
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
216
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Insulin: Dosing Regimen and Adverse Effects
134
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
134
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
